🇺🇸 FDA
Pipeline program

Carboplatin

IPM3002

Phase 3 small_molecule active

Quick answer

Carboplatin for Extensive-Stage Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Alaunos Therapeutics
Indication
Extensive-Stage Small Cell Lung Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials